PNC Financial Services Group
EPZM

PNC Financial Services Group’s Epizyme, Inc EPZM Stock Holding History

PNC Financial Services Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-600
Closed -$5K – 4339
2021
Q1 		$5K Hold
600
– – ﹤0.01% 3837
2020
Q4 		$7K Hold
600
– – ﹤0.01% 3663
2020
Q3 		$7K Hold
600
– – ﹤0.01% 3616
2020
Q2 		$10K Hold
600
– – ﹤0.01% 3486
2020
Q1 		$9K Buy
+600
New +$12.9K ﹤0.01% 3460
2017
Q2 		– Sell
-2,000
Closed -$34K – 4255
2017
Q1 		$34K Buy
+2,000
New +$26.6K ﹤0.01% 3079

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

PNC Financial Services Group's EPZM Position: Q2 2021 in Review

PNC Financial Services Group sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 600 shares — an estimated $5K sold.

PNC Financial Services Group first reported a position in EPZM in Q1 2017 and held it in 6 quarters. The position peaked at $34K in Q1 2017. 126 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • PNC Financial Services Group reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 600 Epizyme, Inc shares in Q2 2021, an estimated $5K.
  • PNC Financial Services Group first reported a position in Epizyme, Inc in Q1 2017 and held it in 6 quarters.
  • PNC Financial Services Group's Epizyme, Inc position peaked at $34K in Q1 2017.
  • 126 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on PNC Financial Services Group's 13F filing for Q2 2021, filed 6 Aug 2021.